Active requests
6Across 4 manufacturersPHASE 00 · PROGRAM WORKSPACE
Formulary onboarding overview
Track each therapy from addition request through review, decision, agreements and activation.
Reviews due
82 overdue this weekReady for decision
3All required reviews completeActive therapies
42 additional pathways in draftOnboarding portfolio
Program-level therapy records currently in progress
| Therapy | Current stage | Owner | Progress | Status |
|---|---|---|---|---|
| NexaCell CD19 CAR-TNorthstar Bio · FO-2026-018 | Multidisciplinary review | Alex Morgan | 36% | At risk |
| GeneSight AAV TherapyHelixNova · FO-2026-017 | Agreements | Alex Morgan | 64% | On track |
| MarrowMap BCMA CAR-TArcwell Therapeutics · FO-2026-016 | Ready to activate | Alex Morgan | 91% | Decision complete |
| VelaGene AAV-9VelaGenics · FO-2026-015 | Additional information | Alex Morgan | 18% | Action needed |
Needs attention
Items requiring program action
Portfolio by stage
Where therapy onboarding work is concentrated